Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1992 Jul;51(7):919–925. doi: 10.1136/ard.51.7.919

Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications.

P R Colville-Nash 1, D L Scott 1
PMCID: PMC1004784  PMID: 1378718

Abstract

Rheumatoid arthritis can be considered as one of the family of 'angiogenesis dependent diseases'. Angiogenesis in rheumatoid arthritis is controlled by a variety of factors found in the synovial fluid and pannus tissue. Modulation of the angiogenic component of the disease may alter the pathogenesis of the condition, and subsequent cartilage and joint destruction, by reducing the area of the endothelium in the pannus and restricting pannus growth. Current therapeutic strategies exert, to varying extents, an inhibitory effect on the angiogenic process. In particular, the mode of action of the slow acting antirheumatic drugs may be due to their effect on the angiogenic response. The development of novel angiostatic treatments for chronic inflammatory joint disease may lead to a new therapeutic approach in controlling disease progression.

Full text

PDF
921

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amemiya K., Suzuki J., Kimura M. [Mechanism of action of pronase on chronic proliferative inflammation including granuloma angiogenesis in mice]. Nihon Yakurigaku Zasshi. 1986 Oct;88(4):279–288. doi: 10.1254/fpj.88.279. [DOI] [PubMed] [Google Scholar]
  2. Arend W. P., Dayer J. M. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum. 1990 Mar;33(3):305–315. doi: 10.1002/art.1780330302. [DOI] [PubMed] [Google Scholar]
  3. Ausprunk D. H., Folkman J. Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc Res. 1977 Jul;14(1):53–65. doi: 10.1016/0026-2862(77)90141-8. [DOI] [PubMed] [Google Scholar]
  4. Bagavandoss P., Wilks J. W. Isolation and characterization of microvascular endothelial cells from developing corpus luteum. Biol Reprod. 1991 Jun;44(6):1132–1139. doi: 10.1095/biolreprod44.6.1132. [DOI] [PubMed] [Google Scholar]
  5. Baird A., Esch F., Gospodarowicz D., Guillemin R. Retina- and eye-derived endothelial cell growth factors: partial molecular characterization and identity with acidic and basic fibroblast growth factors. Biochemistry. 1985 Dec 31;24(27):7855–7860. doi: 10.1021/bi00348a001. [DOI] [PubMed] [Google Scholar]
  6. Baird A., Ling N. Fibroblast growth factors are present in the extracellular matrix produced by endothelial cells in vitro: implications for a role of heparinase-like enzymes in the neovascular response. Biochem Biophys Res Commun. 1987 Jan 30;142(2):428–435. doi: 10.1016/0006-291x(87)90292-0. [DOI] [PubMed] [Google Scholar]
  7. Bar R. S., Boes M., Booth B. A., Dake B. L., Henley S., Hart M. N. The effects of platelet-derived growth factor in cultured microvessel endothelial cells. Endocrinology. 1989 Apr;124(4):1841–1848. doi: 10.1210/endo-124-4-1841. [DOI] [PubMed] [Google Scholar]
  8. Barnard J. A., Lyons R. M., Moses H. L. The cell biology of transforming growth factor beta. Biochim Biophys Acta. 1990 Jun 1;1032(1):79–87. doi: 10.1016/0304-419x(90)90013-q. [DOI] [PubMed] [Google Scholar]
  9. Beranek J. T. Prednisolone enhancement of primary endocrine anticancer treatment: a possible anti-angiogenic effect. Br J Cancer. 1989 Jul;60(1):149–149. doi: 10.1038/bjc.1989.238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Berman M., Winthrop S., Ausprunk D., Rose J., Langer R., Gage J. Plasminogen activator (urokinase) causes vascularization of the cornea. Invest Ophthalmol Vis Sci. 1982 Feb;22(2):191–199. [PubMed] [Google Scholar]
  11. Beutler B., Cerami A. Cachectin and tumour necrosis factor as two sides of the same biological coin. Nature. 1986 Apr 17;320(6063):584–588. doi: 10.1038/320584a0. [DOI] [PubMed] [Google Scholar]
  12. Brown K. D., Littlewood C. J. Endothelin stimulates DNA synthesis in Swiss 3T3 cells. Synergy with polypeptide growth factors. Biochem J. 1989 Nov 1;263(3):977–980. doi: 10.1042/bj2630977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Brown R. A., Tomlinson I. W., Hill C. R., Weiss J. B., Phillips P., Kumar S. Relationship of angiogenesis factor in synovial fluid to various joint diseases. Ann Rheum Dis. 1983 Jun;42(3):301–307. doi: 10.1136/ard.42.3.301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Brown R. A., Weiss J. B. Neovascularisation and its role in the osteoarthritic process. Ann Rheum Dis. 1988 Nov;47(11):881–885. doi: 10.1136/ard.47.11.881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Carswell E. A., Old L. J., Kassel R. L., Green S., Fiore N., Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A. 1975 Sep;72(9):3666–3670. doi: 10.1073/pnas.72.9.3666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Chander C. L., Colville-Nash P. R., Moore A. R., Howat D. W., Desa F. M., Willoughby D. A. The effects of heparin and cortisone on an experimental model of pannus. Int J Tissue React. 1989;11(3):113–116. [PubMed] [Google Scholar]
  17. Clark R. A. Potential roles of fibronectin in cutaneous wound repair. Arch Dermatol. 1988 Feb;124(2):201–206. [PubMed] [Google Scholar]
  18. Connolly D. T., Heuvelman D. M., Nelson R., Olander J. V., Eppley B. L., Delfino J. J., Siegel N. R., Leimgruber R. M., Feder J. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest. 1989 Nov;84(5):1470–1478. doi: 10.1172/JCI114322. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Connolly D. T., Olander J. V., Heuvelman D., Nelson R., Monsell R., Siegel N., Haymore B. L., Leimgruber R., Feder J. Human vascular permeability factor. Isolation from U937 cells. J Biol Chem. 1989 Nov 25;264(33):20017–20024. [PubMed] [Google Scholar]
  20. Courty J., Chevallier B., Moenner M., Loret C., Lagente O., Bohlen P., Courtois Y., Barritault D. Evidence for FGF-like growth factor in adult bovine retina: analogies with EDGF I. Biochem Biophys Res Commun. 1986 Apr 14;136(1):102–108. doi: 10.1016/0006-291x(86)90882-x. [DOI] [PubMed] [Google Scholar]
  21. Crum R., Szabo S., Folkman J. A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment. Science. 1985 Dec 20;230(4732):1375–1378. doi: 10.1126/science.2416056. [DOI] [PubMed] [Google Scholar]
  22. Dejana E., Languino L. R., Polentarutti N., Balconi G., Ryckewaert J. J., Larrieu M. J., Donati M. B., Mantovani A., Marguerie G. Interaction between fibrinogen and cultured endothelial cells. Induction of migration and specific binding. J Clin Invest. 1985 Jan;75(1):11–18. doi: 10.1172/JCI111661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. DiCorleto P. E., Bowen-Pope D. F. Cultured endothelial cells produce a platelet-derived growth factor-like protein. Proc Natl Acad Sci U S A. 1983 Apr;80(7):1919–1923. doi: 10.1073/pnas.80.7.1919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Fassbender H. G., Simmling-Annefeld M. The potential aggressiveness of synovial tissue in rheumatoid arthritis. J Pathol. 1983 Mar;139(3):399–406. doi: 10.1002/path.1711390314. [DOI] [PubMed] [Google Scholar]
  25. Fett J. W., Strydom D. J., Lobb R. R., Alderman E. M., Bethune J. L., Riordan J. F., Vallee B. L. Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry. 1985 Sep 24;24(20):5480–5486. doi: 10.1021/bi00341a030. [DOI] [PubMed] [Google Scholar]
  26. Fibbi G., Ziche M., Morbidelli L., Magnelli L., Del Rosso M. Interaction of urokinase with specific receptors stimulates mobilization of bovine adrenal capillary endothelial cells. Exp Cell Res. 1988 Dec;179(2):385–395. doi: 10.1016/0014-4827(88)90277-7. [DOI] [PubMed] [Google Scholar]
  27. Folkman J. How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial Award lecture. Cancer Res. 1986 Feb;46(2):467–473. [PubMed] [Google Scholar]
  28. Folkman J., Ingber D. E. Angiostatic steroids. Method of discovery and mechanism of action. Ann Surg. 1987 Sep;206(3):374–383. doi: 10.1097/00000658-198709000-00016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Folkman J., Langer R., Linhardt R. J., Haudenschild C., Taylor S. Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone. Science. 1983 Aug 19;221(4612):719–725. doi: 10.1126/science.6192498. [DOI] [PubMed] [Google Scholar]
  30. Folkman J., Weisz P. B., Joullié M. M., Li W. W., Ewing W. R. Control of angiogenesis with synthetic heparin substitutes. Science. 1989 Mar 17;243(4897):1490–1493. doi: 10.1126/science.2467380. [DOI] [PubMed] [Google Scholar]
  31. Friesel R., Komoriya A., Maciag T. Inhibition of endothelial cell proliferation by gamma-interferon. J Cell Biol. 1987 Mar;104(3):689–696. doi: 10.1083/jcb.104.3.689. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Fràter-Schröder M., Müller G., Birchmeier W., Böhlen P. Transforming growth factor-beta inhibits endothelial cell proliferation. Biochem Biophys Res Commun. 1986 May 29;137(1):295–302. doi: 10.1016/0006-291x(86)91209-x. [DOI] [PubMed] [Google Scholar]
  33. Fràter-Schröder M., Risau W., Hallmann R., Gautschi P., Böhlen P. Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc Natl Acad Sci U S A. 1987 Aug;84(15):5277–5281. doi: 10.1073/pnas.84.15.5277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Gimenez-Gallego G., Rodkey J., Bennett C., Rios-Candelore M., DiSalvo J., Thomas K. Brain-derived acidic fibroblast growth factor: complete amino acid sequence and homologies. Science. 1985 Dec 20;230(4732):1385–1388. doi: 10.1126/science.4071057. [DOI] [PubMed] [Google Scholar]
  35. Giulian D., Chen J., Ingeman J. E., George J. K., Noponen M. The role of mononuclear phagocytes in wound healing after traumatic injury to adult mammalian brain. J Neurosci. 1989 Dec;9(12):4416–4429. doi: 10.1523/JNEUROSCI.09-12-04416.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Grant D. S., Kleinman H. K., Martin G. R. The role of basement membranes in vascular development. Ann N Y Acad Sci. 1990;588:61–72. doi: 10.1111/j.1749-6632.1990.tb13197.x. [DOI] [PubMed] [Google Scholar]
  37. Grootveld M., Blake D. R., Sahinoglu T., Claxson A. W., Mapp P., Stevens C., Allen R. E., Furst A. Control of oxidative damage in rheumatoid arthritis by gold(I)-thiolate drugs. Free Radic Res Commun. 1990;10(4-5):199–220. doi: 10.3109/10715769009149889. [DOI] [PubMed] [Google Scholar]
  38. Gross J. L., Moscatelli D., Jaffe E. A., Rifkin D. B. Plasminogen activator and collagenase production by cultured capillary endothelial cells. J Cell Biol. 1982 Dec;95(3):974–981. doi: 10.1083/jcb.95.3.974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Gryglewski R. J., Botting R. M., Vane J. R. Mediators produced by the endothelial cell. Hypertension. 1988 Dec;12(6):530–548. doi: 10.1161/01.hyp.12.6.530. [DOI] [PubMed] [Google Scholar]
  40. Haynes W. L., Proia A. D., Klintworth G. K. Effect of inhibitors of arachidonic acid metabolism on corneal neovascularization in the rat. Invest Ophthalmol Vis Sci. 1989 Jul;30(7):1588–1593. [PubMed] [Google Scholar]
  41. Herron G. S., Banda M. J., Clark E. J., Gavrilovic J., Werb Z. Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors. J Biol Chem. 1986 Feb 25;261(6):2814–2818. [PubMed] [Google Scholar]
  42. Hirata S., Matsubara T., Saura R., Tateishi H., Hirohata K. Inhibition of in vitro vascular endothelial cell proliferation and in vivo neovascularization by low-dose methotrexate. Arthritis Rheum. 1989 Sep;32(9):1065–1073. doi: 10.1002/anr.1780320903. [DOI] [PubMed] [Google Scholar]
  43. Ingber D., Fujita T., Kishimoto S., Sudo K., Kanamaru T., Brem H., Folkman J. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature. 1990 Dec 6;348(6301):555–557. doi: 10.1038/348555a0. [DOI] [PubMed] [Google Scholar]
  44. Inyang A. L., Bikfalvi A., Lu H., Tobelem G. Chloroquine's modulation of endothelial cell activity induced with basic fibroblast growth factor and human serum: effect on mitogenesis, protease production and cell migration. Cell Biol Int Rep. 1990 Jan;14(1):35–46. doi: 10.1016/0309-1651(90)90069-b. [DOI] [PubMed] [Google Scholar]
  45. Inyang A. L., Tobelem G. Tissue-plasminogen activator stimulates endothelial cell migration in wound assays. Biochem Biophys Res Commun. 1990 Sep 28;171(3):1326–1332. doi: 10.1016/0006-291x(90)90831-7. [DOI] [PubMed] [Google Scholar]
  46. Ishikawa F., Miyazono K., Hellman U., Drexler H., Wernstedt C., Hagiwara K., Usuki K., Takaku F., Risau W., Heldin C. H. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature. 1989 Apr 13;338(6216):557–562. doi: 10.1038/338557a0. [DOI] [PubMed] [Google Scholar]
  47. Jarasch E. D., Bruder G., Heid H. W. Significance of xanthine oxidase in capillary endothelial cells. Acta Physiol Scand Suppl. 1986;548:39–46. [PubMed] [Google Scholar]
  48. Jirik F. R., Podor T. J., Hirano T., Kishimoto T., Loskutoff D. J., Carson D. A., Lotz M. Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells. J Immunol. 1989 Jan 1;142(1):144–147. [PubMed] [Google Scholar]
  49. Joyce N. C., Matkin E. D., Neufeld A. H. Corneal endothelial wound closure in vitro. Effects of EGF and/or indomethacin. Invest Ophthalmol Vis Sci. 1989 Jul;30(7):1548–1559. [PubMed] [Google Scholar]
  50. Joyce N. C., Meklir B., Neufeld A. H. In vitro pharmacologic separation of corneal endothelial migration and spreading responses. Invest Ophthalmol Vis Sci. 1990 Sep;31(9):1816–1826. [PubMed] [Google Scholar]
  51. Kalebic T., Garbisa S., Glaser B., Liotta L. A. Basement membrane collagen: degradation by migrating endothelial cells. Science. 1983 Jul 15;221(4607):281–283. doi: 10.1126/science.6190230. [DOI] [PubMed] [Google Scholar]
  52. Keck P. J., Hauser S. D., Krivi G., Sanzo K., Warren T., Feder J., Connolly D. T. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science. 1989 Dec 8;246(4935):1309–1312. doi: 10.1126/science.2479987. [DOI] [PubMed] [Google Scholar]
  53. Knighton D. R., Hunt T. K., Thakral K. K., Goodson W. H., 3rd Role of platelets and fibrin in the healing sequence: an in vivo study of angiogenesis and collagen synthesis. Ann Surg. 1982 Oct;196(4):379–388. doi: 10.1097/00000658-198210000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Koch A. E., Polverini P. J., Leibovich S. J. Stimulation of neovascularization by human rheumatoid synovial tissue macrophages. Arthritis Rheum. 1986 Apr;29(4):471–479. doi: 10.1002/art.1780290403. [DOI] [PubMed] [Google Scholar]
  55. Lobb R. R., Fett J. W. Purification of two distinct growth factors from bovine neural tissue by heparin affinity chromatography. Biochemistry. 1984 Dec 18;23(26):6295–6299. doi: 10.1021/bi00321a001. [DOI] [PubMed] [Google Scholar]
  56. Loskutoff D. J., Edgington T. E. Synthesis of a fibrinolytic activator and inhibitor by endothelial cells. Proc Natl Acad Sci U S A. 1977 Sep;74(9):3903–3907. doi: 10.1073/pnas.74.9.3903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Madri J. A., Williams S. K. Capillary endothelial cell cultures: phenotypic modulation by matrix components. J Cell Biol. 1983 Jul;97(1):153–165. doi: 10.1083/jcb.97.1.153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Mantovani A., Dejana E. Cytokines as communication signals between leukocytes and endothelial cells. Immunol Today. 1989 Nov;10(11):370–375. doi: 10.1016/0167-5699(89)90270-3. [DOI] [PubMed] [Google Scholar]
  59. Marcum J. A., McKenney J. B., Rosenberg R. D. Acceleration of thrombin-antithrombin complex formation in rat hindquarters via heparinlike molecules bound to the endothelium. J Clin Invest. 1984 Aug;74(2):341–350. doi: 10.1172/JCI111429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Marquardt H., Hunkapiller M. W., Hood L. E., Twardzik D. R., De Larco J. E., Stephenson J. R., Todaro G. J. Transforming growth factors produced by retrovirus-transformed rodent fibroblasts and human melanoma cells: amino acid sequence homology with epidermal growth factor. Proc Natl Acad Sci U S A. 1983 Aug;80(15):4684–4688. doi: 10.1073/pnas.80.15.4684. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Matsubara T., Saura R., Hirohata K., Ziff M. Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by D-penicillamine. J Clin Invest. 1989 Jan;83(1):158–167. doi: 10.1172/JCI113853. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Matsubara T., Ziff M. Inhibition of human endothelial cell proliferation by gold compounds. J Clin Invest. 1987 May;79(5):1440–1446. doi: 10.1172/JCI112972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. McLaughlin B., Cawston T., Weiss J. B. Activation of the matrix metalloproteinase inhibitor complex by a low molecular weight angiogenic factor. Biochim Biophys Acta. 1991 Mar 4;1073(2):295–298. doi: 10.1016/0304-4165(91)90134-3. [DOI] [PubMed] [Google Scholar]
  64. Mican J. M., Metcalfe D. D. Arthritis and mast cell activation. J Allergy Clin Immunol. 1990 Oct;86(4 Pt 2):677–683. doi: 10.1016/s0091-6749(05)80240-4. [DOI] [PubMed] [Google Scholar]
  65. Mignatti P., Mazzieri R., Rifkin D. B. Expression of the urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor. J Cell Biol. 1991 Jun;113(5):1193–1201. doi: 10.1083/jcb.113.5.1193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Mignatti P., Tsuboi R., Robbins E., Rifkin D. B. In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases. J Cell Biol. 1989 Feb;108(2):671–682. doi: 10.1083/jcb.108.2.671. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Moses M. A., Sudhalter J., Langer R. Identification of an inhibitor of neovascularization from cartilage. Science. 1990 Jun 15;248(4961):1408–1410. doi: 10.1126/science.1694043. [DOI] [PubMed] [Google Scholar]
  68. Norioka K., Hara M., Kitani A., Hirose T., Hirose W., Harigai M., Suzuki K., Kawakami M., Tabata H., Kawagoe M. Inhibitory effect of human recombinant interleukin-1 alpha and beta on growth of human vascular endothelial cells. Biochem Biophys Res Commun. 1987 Jun 15;145(2):969–975. doi: 10.1016/0006-291x(87)91060-6. [DOI] [PubMed] [Google Scholar]
  69. Orlidge A., D'Amore P. A. Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J Cell Biol. 1987 Sep;105(3):1455–1462. doi: 10.1083/jcb.105.3.1455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Owen K., Gomolka D., Droller M. J. Production of prostaglandin E2 by tumor cells in vitro. Cancer Res. 1980 Sep;40(9):3167–3171. [PubMed] [Google Scholar]
  71. Pepper M. S., Vassalli J. D., Montesano R., Orci L. Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells. J Cell Biol. 1987 Dec;105(6 Pt 1):2535–2541. doi: 10.1083/jcb.105.6.2535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Pober J. S., Gimbrone M. A., Jr Expression of Ia-like antigens by human vascular endothelial cells is inducible in vitro: demonstration by monoclonal antibody binding and immunoprecipitation. Proc Natl Acad Sci U S A. 1982 Nov;79(21):6641–6645. doi: 10.1073/pnas.79.21.6641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Rifkin D. B., Moscatelli D. Recent developments in the cell biology of basic fibroblast growth factor. J Cell Biol. 1989 Jul;109(1):1–6. doi: 10.1083/jcb.109.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Roberts A. B., Sporn M. B., Assoian R. K., Smith J. M., Roche N. S., Wakefield L. M., Heine U. I., Liotta L. A., Falanga V., Kehrl J. H. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A. 1986 Jun;83(12):4167–4171. doi: 10.1073/pnas.83.12.4167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Rooney M., Condell D., Quinlan W., Daly L., Whelan A., Feighery C., Bresnihan B. Analysis of the histologic variation of synovitis in rheumatoid arthritis. Arthritis Rheum. 1988 Aug;31(8):956–963. doi: 10.1002/art.1780310803. [DOI] [PubMed] [Google Scholar]
  76. Rubin K., Terracio L., Rönnstrand L., Heldin C. H., Klareskog L. Expression of platelet-derived growth factor receptors is induced on connective tissue cells during chronic synovial inflammation. Scand J Immunol. 1988 Mar;27(3):285–294. doi: 10.1111/j.1365-3083.1988.tb02349.x. [DOI] [PubMed] [Google Scholar]
  77. Saiki I., Murata J., Makabe T., Nishi N., Tokura S., Azuma I. Inhibition of tumor angiogenesis by a synthetic cell-adhesive polypeptide containing the Arg-Gly-Asp (RGD) sequence of fibronectin, poly(RGD). Jpn J Cancer Res. 1990 Jun-Jul;81(6-7):668–675. doi: 10.1111/j.1349-7006.1990.tb02625.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Saksela O., Rifkin D. B. Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity. J Cell Biol. 1990 Mar;110(3):767–775. doi: 10.1083/jcb.110.3.767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Sano H., Forough R., Maier J. A., Case J. P., Jackson A., Engleka K., Maciag T., Wilder R. L. Detection of high levels of heparin binding growth factor-1 (acidic fibroblast growth factor) in inflammatory arthritic joints. J Cell Biol. 1990 Apr;110(4):1417–1426. doi: 10.1083/jcb.110.4.1417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Schreiber A. B., Winkler M. E., Derynck R. Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor. Science. 1986 Jun 6;232(4755):1250–1253. doi: 10.1126/science.2422759. [DOI] [PubMed] [Google Scholar]
  81. Shapiro R., Riordan J. F., Vallee B. L. Characteristic ribonucleolytic activity of human angiogenin. Biochemistry. 1986 Jun 17;25(12):3527–3532. doi: 10.1021/bi00360a008. [DOI] [PubMed] [Google Scholar]
  82. Shapiro R., Vallee B. L. Human placental ribonuclease inhibitor abolishes both angiogenic and ribonucleolytic activities of angiogenin. Proc Natl Acad Sci U S A. 1987 Apr;84(8):2238–2241. doi: 10.1073/pnas.84.8.2238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Shing Y., Folkman J., Sullivan R., Butterfield C., Murray J., Klagsbrun M. Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor. Science. 1984 Mar 23;223(4642):1296–1299. doi: 10.1126/science.6199844. [DOI] [PubMed] [Google Scholar]
  84. Shiozawa S., Shiozawa K., Tanaka Y., Morimoto I., Uchihashi M., Fujita T., Hirohata K., Hirata Y., Imura S. Human epidermal growth factor for the stratification of synovial lining layer and neovascularisation in rheumatoid arthritis. Ann Rheum Dis. 1989 Oct;48(10):820–828. doi: 10.1136/ard.48.10.820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Silverman K. J., Lund D. P., Zetter B. R., Lainey L. L., Shahood J. A., Freiman D. G., Folkman J., Barger A. C. Angiogenic activity of adipose tissue. Biochem Biophys Res Commun. 1988 May 31;153(1):347–352. doi: 10.1016/s0006-291x(88)81229-4. [DOI] [PubMed] [Google Scholar]
  86. Silverman K. J., Lund D. P., Zetter B. R., Lainey L. L., Shahood J. A., Freiman D. G., Folkman J., Barger A. C. Angiogenic activity of adipose tissue. Biochem Biophys Res Commun. 1988 May 31;153(1):347–352. doi: 10.1016/s0006-291x(88)81229-4. [DOI] [PubMed] [Google Scholar]
  87. Springer T. A. Adhesion receptors of the immune system. Nature. 1990 Aug 2;346(6283):425–434. doi: 10.1038/346425a0. [DOI] [PubMed] [Google Scholar]
  88. Stenson W. F., Parker C. W. Prostaglandins, macrophages, and immunity. J Immunol. 1980 Jul;125(1):1–5. [PubMed] [Google Scholar]
  89. Stevens C. R., Blake D. R., Merry P., Revell P. A., Levick J. R. A comparative study by morphometry of the microvasculature in normal and rheumatoid synovium. Arthritis Rheum. 1991 Dec;34(12):1508–1513. doi: 10.1002/art.1780341206. [DOI] [PubMed] [Google Scholar]
  90. Stokes C. L., Weisz P. B., Williams S. K., Lauffenburger D. A. Inhibition of microvascular endothelial cell migration by beta-cyclodextrin tetradecasulfate and hydrocortisone. Microvasc Res. 1990 Sep;40(2):279–284. doi: 10.1016/0026-2862(90)90025-m. [DOI] [PubMed] [Google Scholar]
  91. Strydom D. J., Fett J. W., Lobb R. R., Alderman E. M., Bethune J. L., Riordan J. F., Vallee B. L. Amino acid sequence of human tumor derived angiogenin. Biochemistry. 1985 Sep 24;24(20):5486–5494. doi: 10.1021/bi00341a031. [DOI] [PubMed] [Google Scholar]
  92. Takigawa M., Nishida Y., Suzuki F., Kishi J., Yamashita K., Hayakawa T. Induction of angiogenesis in chick yolk-sac membrane by polyamines and its inhibition by tissue inhibitors of metalloproteinases (TIMP and TIMP-2). Biochem Biophys Res Commun. 1990 Sep 28;171(3):1264–1271. doi: 10.1016/0006-291x(90)90822-5. [DOI] [PubMed] [Google Scholar]
  93. Uitto V. J., Schwartz D., Veis A. Degradation of basement-membrane collagen by neutral proteases from human leukocytes. Eur J Biochem. 1980 Apr;105(2):409–417. doi: 10.1111/j.1432-1033.1980.tb04515.x. [DOI] [PubMed] [Google Scholar]
  94. Vane J. R. Prostaglandins as mediators of inflammation. Adv Prostaglandin Thromboxane Res. 1976;2:791–801. [PubMed] [Google Scholar]
  95. Vlodavsky I., Folkman J., Sullivan R., Fridman R., Ishai-Michaeli R., Sasse J., Klagsbrun M. Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. Proc Natl Acad Sci U S A. 1987 Apr;84(8):2292–2296. doi: 10.1073/pnas.84.8.2292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Vlodavsky I., Korner G., Ishai-Michaeli R., Bashkin P., Bar-Shavit R., Fuks Z. Extracellular matrix-resident growth factors and enzymes: possible involvement in tumor metastasis and angiogenesis. Cancer Metastasis Rev. 1990 Nov;9(3):203–226. doi: 10.1007/BF00046361. [DOI] [PubMed] [Google Scholar]
  97. Werb Z., Banda M. J., Jones P. A. Degradation of connective tissue matrices by macrophages. I. Proteolysis of elastin, glycoproteins, and collagen by proteinases isolated from macrophages. J Exp Med. 1980 Nov 1;152(5):1340–1357. doi: 10.1084/jem.152.5.1340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Yang E. Y., Moses H. L. Transforming growth factor beta 1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane. J Cell Biol. 1990 Aug;111(2):731–741. doi: 10.1083/jcb.111.2.731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Zoon K. C., Karasaki Y., zur Nedden D. L., Hu R. Q., Arnheiter H. Modulation of epidermal growth factor receptors by human alpha interferon. Proc Natl Acad Sci U S A. 1986 Nov;83(21):8226–8230. doi: 10.1073/pnas.83.21.8226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. de Larco J. E., Todaro G. J. Growth factors from murine sarcoma virus-transformed cells. Proc Natl Acad Sci U S A. 1978 Aug;75(8):4001–4005. doi: 10.1073/pnas.75.8.4001. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES